Recognition of Losses on Investment Partnerships and Equity-Method Investment Losses
First written in FY2023-Q2. 3 of 8 entries say "Worsened", first in FY2023. Latest entry: 2026-09-11.
Pharma Foods International moved to the "Worse" side of this theme in 2025, the same year as the typical company in this theme.
The whole theme swung hardest in 2023: 3 of 17 companies on the "Worse" side.
1 other company's latest entry also says "Worsened".
- 2026-09-11WorsenedRevision of earnings forecasts
「Equity-method investment loss 131 203」
The equity-method investment loss increased from ¥131 million in the previous fiscal year to ¥203 million. - FY2025-H1WorsenedAnnual report
「Loss on equity-method investments 67」
During the current interim consolidated accounting period, the company recognized a ¥67 million loss on equity-method investments, increasing from ¥0 million recognized in the same period of the previous year. - FY2024MitigatedAnnual report
「Loss on management of investment business partnership 9 Loss on equity-method investments 35」
The loss on management of an investment business partnership declined from ¥14 million in the previous fiscal year to ¥9 million, while the loss on equity-method investments declined from ¥82 million to ¥35 million. - FY2024-Q3MitigatedAnnual report
「Loss on management of investment business partnership 2 Loss on equity-method investments 28」
The loss on management of an investment business partnership was ¥2 million and the loss on equity-method investments was ¥28 million, with the scale of losses declining from ¥10 million and ¥61 million, respectively, in the same period of the previous year. - FY2024-Q2MitigatedAnnual report
「Loss on management of investment business partnership 10 2 Loss on equity-method investments 38 0」
The loss on management of an investment business partnership declined from ¥10 million in the same period of the previous year to ¥2 million, while the loss on equity-method investments declined from ¥38 million in the same period of the previous year to nil. - FY2024-Q1Coexistence of reduced loss items and new loss recognitionAnnual report
「Loss on management of investment business partnership 2 Loss on equity-method investments 1」
During the cumulative first quarter of the current consolidated fiscal year, the company newly recognized a ¥2 million loss on management of an investment business partnership, while the loss on equity-method investments was ¥1 million, down from ¥12 million in the same period of the previous year. - FY2023WorsenedAnnual report
「Loss on management of investment business partnership 14 Loss on equity-method investments 82」
The company recognized a ¥14 million loss on management of an investment business partnership and an ¥82 million loss on equity-method investments, with the scale of losses increasing from ¥10 million and ¥38 million, respectively, in the previous quarter. - FY2023-Q2First statedAnnual report
「Loss on management of investment business partnership 10 Loss on equity-method investments 38」
During the cumulative second quarter of the current consolidated fiscal year, the company recognized a ¥10 million loss on management of an investment business partnership and a ¥38 million loss on equity-method investments as non-operating expenses.